Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059333) titled 'A study on the clinical course of chronic hepatitis B under nucleos(t)ide analogue therapy' on Oct. 8.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: The University of Osaka
Condition:
Chronic hepatitis B
Recruitment Status: Recruiting
Phase: Not selected
Date of First Enrollment: 2025/09/26
Target Sample Size: 2500
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066571
Published by HT Digital Content Services with permission from Health Daily Digest....